USA VC Funds

BonAngels Venture Partners is one of Korea's pioneering early-stage venture capital firms, co-founded in Seoul in 2006 by BG Chang, Simon Kang, and Inae Song as an angel investment team before incorporating as a formal entity in 2010. The firm manages approximately $80 million in assets and most recently raised Pacemaker Fund 4 at $100 million — notably, 57% of that capital came from successful startup founders previously backed by BonAngels. The firm has invested in more than 270 startups across seed and Series A stages, leading rounds with typical check sizes between $1 million and $5 million. The portfolio has produced four unicorns, 22 merger and acquisition exits, and two IPOs. Notable investments include Woowahan Brothers (Korea's leading food delivery platform), Daily Hotel (hotel reservation app), Jobplanet (Korea's Glassdoor equivalent), Channel Talk, and Remex. BonAngels focuses on IT and mobile, SaaS, gaming, fintech, and education, with particular interest in Korean companies targeting global markets. Each portfolio company is assigned a designated executive partner and investment associate, ensuring consistent, hands-on engagement rather than passive capital. BonAngels operates with a team of 17 including seven partners, and has built a distinctive LP base of returning founders — a signal of portfolio quality and trust that distinguishes the firm within the Korean venture ecosystem.

BOND Capital is a global technology investment firm that focuses on supporting visionary founders throughout their entire innovation and growth lifecycle. Established in 2019, BOND is a spinout of the Kleiner Perkins Digital Growth Fund and was founded by Mary Meeker, along with other key partners. The firm invests in high-growth internet companies, emphasizing long-term partnerships with entrepreneurs who are transforming their industries. Notable investments include prominent companies like Stripe, Canva, and Airbnb. BOND Capital aims to leverage its extensive network and expertise to provide strategic guidance and resources to its portfolio companies. Based in San Francisco, BOND operates with a global outlook, seeking opportunities in diverse markets to support groundbreaking technological advancements​.

Bonfire Ventures is a venture capital firm based in Santa Monica, California, founded in 2017 by Mark Mullen and Jim Andelman. The firm specializes in seed-stage investments in B2B software companies, aiming to support founders with significant ambitions in the tech space. Bonfire Ventures' strategy involves making initial investments ranging from $1 million to $5 million, often leading the first institutional round for their portfolio companies. The firm has raised multiple funds, including a $168 million third seed fund and a $63 million second opportunity fund, totaling $231 million in 2022. Bonfire Ventures has built a strong portfolio of over 198 investments, including notable companies like TaxJar, The Trade Desk, and Boulevard. Bonfire Ventures is known for its deep commitment to its portfolio companies, providing not just capital but also strategic guidance and operational support to help startups scale successfully. The team includes experienced professionals like Brett Queener, Jennifer Richard, and Brian MacInnes, who bring a wealth of industry knowledge and expertise to their roles.

Bonsal Capital, established in 1999 and headquartered in Baltimore, MD, is a venture capital firm focusing on seed-stage investments. The firm is renowned for its commitment to supporting underrepresented founders and emerging venture managers, with 80% of its investments directed towards these groups. Their portfolio is heavily centered around education and workforce technology, reflecting their mission-driven approach to create both social and financial returns. Notable investments include companies like Allovue, KidzToPros, and EveryDay Labs. These investments highlight Bonsal Capital's emphasis on tech-enabled solutions that address significant problems in education and workforce development. The firm's strategy involves not only providing capital but also leveraging their extensive experience and networks to guide companies through their growth trajectories. The team is led by Frank Bonsal III, who brings extensive experience in both venture capital and education sectors. Bonsal Capital has made over 40 investments, with 14 notable exits, and they continue to be a pivotal player in supporting innovative solutions within their focus areas.

Booga Ventures is a global private investment, advisory, and mentoring firm based in San Mateo, California, founded in 2009 by Young Song. The firm invests in early-stage technology startups across the United States and Asia at the prototyping stage, deploying working capital and equity investment from $30,000 to $250,000 — with over $3 million invested from its corporate capital fund across 13 portfolio companies. Focus sectors include SaaS, education, productivity tools, cloud computing, and AI. The portfolio includes two notable public market outcomes: Box (NYSE IPO at a $1.63 billion market cap) and Mobi Days (listed on Korea Exchange in February 2021). Two portfolio companies have been acquired: VoiceBox Technologies and Clickable (acquired by Brand Networks in May 2019). Chartmetric, the music analytics platform, is among active holdings. Young Song brings 25-plus years of technology leadership as co-founder and CEO of NComputing, a desktop virtualization company ranked as the world's third-largest thin client vendor by IDC with 70,000-plus enterprise customers across 140 countries. Booga operates at the earliest stage of company formation, where founder mentorship and strategic introduction carry as much weight as capital. Song's background in enterprise technology and cross-border US-Asia markets gives portfolio founders access to distribution relationships and corporate buyer networks that are difficult to replicate through traditional VC channels.

Boomerang Ventures is a healthcare-focused venture studio and VC fund headquartered in Indianapolis, Indiana, founded in 2019 by Oscar Moralez. The firm invests $500,000 to $2 million at pre-seed through seed stages in early-stage healthcare startups building connected medical devices, digital health tools, tech-enabled health services, and healthcare informatics. Boomerang leads rounds and has made 22 investments. In February 2024, nationally recognized nonprofit managed care organization CareSource joined as a limited partner, deepening the fund's presence in the Midwestern healthcare market. Portfolio companies include Impower Health, Bedside Bike, WithYou Therapeutics, Lizzy Care (AI-driven at-home dementia care, $2.6 million seed in February 2025), and SiteLabs (pharmacy-based preventive screenings, $2 million seed led by Boomerang in November 2025). The portfolio spans healthtech, connected medical devices, AI, and data analytics applications for care delivery. Boomerang operates as both a studio — building companies from the ground up — and as a fund investing in external startups, giving the team direct operating experience that informs its diligence and portfolio support. Oscar Moralez is a serial entrepreneur, mentor, and educator with deep healthcare expertise. Partner and Chief Medical Officer Eric Beier brings 25-plus years of healthcare leadership and investing. The team of four provides hands-on operational support alongside capital.

Boost VC, founded by Adam Draper and Brayton Williams in 2012, is a venture capital firm based in San Mateo, California, that focuses on early-stage investments in frontier technologies. With over $200 million in assets under management, Boost VC typically invests $500,000 in pre-seed startups, supporting over 300 companies. Their portfolio includes notable companies like Coinbase, Protocol Labs, and Snapcard, and spans deep tech sectors such as crypto, VR, AR, AI, space tech, robotics, and bio/health. Boost VC operates a rigorous accelerator program, providing startups with mentorship, resources, and networking opportunities. The three-month program offers intensive support from the Boost VC team and access to a wide network of industry experts and investors. The firm is known for its strong commitment to fostering innovation and diversity within the tech industry, actively supporting women and underrepresented founders. Adam Draper, a fourth-generation venture capitalist, and Brayton Williams, bring extensive experience and a vision for transformative technology startups. The team includes partners like Maddie Callander and Gus Domel, who offer diverse expertise from private aviation to brain health technology.

Bootstrap Venture Partners is a venture capital firm based in Solana Beach, California, founded in 2012 by Jean Balgrosky. The firm draws on more than 40 years of combined team experience in healthcare and technology, bridging the gap between angel investors and traditional VCs. Bootstrap invests $100,000 to $5 million — with a sweet spot around $1.5 million — primarily at seed through Series B, targeting early-stage companies whose products will have meaningful effect on healthcare outcomes or enterprise operations. The firm leads rounds and has made 35 investments. The portfolio has produced one IPO and seven acquisitions, including MD Revolution, Rhombus Energy Solutions, and Immunicon. Active portfolio companies include CirrusMD (virtual care), Scientist.com (research marketplace), Elation Health (clinical EHR), Perceivant, Indigo BioAutomation, and Sinaptica Therapeutics (therapeutic devices, most recent investment in May 2024). The top verticals are enterprise applications, with 15 investments, and healthtech, with 12. Founder and General Partner Jean Balgrosky serves as a board member and operating partner across multiple portfolio companies — functioning as interim CIO in several cases — rather than as a purely passive investor. The entire partner team maintains active governance roles, with the firm's model based on the conviction that early-stage healthcare and technology companies most often fail due to execution gaps, not capital shortfalls.

BootstrapLabs, established in 2008, is a leading venture capital firm based in San Francisco that focuses on investing in early-stage startups, particularly those leveraging Applied Artificial Intelligence (AI). The firm was one of the first to adopt an AI-first investment strategy in 2015. Since then, BootstrapLabs has been dedicated to backing visionary founders who tackle significant and valuable opportunities through AI across various sectors including Future of Work, Mobility, Health, Finance, Cybersecurity, Energy, and Climate. Their portfolio includes notable companies such as unitQ, GetAccept, and Hayden AI. BootstrapLabs prides itself on not only providing financial support but also offering strategic guidance by working closely with top AI talent and domain experts to ensure the growth and success of their portfolio companies. This approach has led to successful exits like AEye, Corpay One, and INDUS.AI. BootstrapLabs is known for making seed-stage investments, typically focusing on startups with the potential to create significant impact both financially and socially. The firm emphasizes that it is possible to achieve strong investment returns while also driving positive change for millions of people.

Borderless Capital is a pioneering venture capital firm focused on the Web3 and blockchain space, particularly leveraging the Algorand ecosystem. Founded in 2018 by Arul Murugan and David García, Borderless Capital operates primarily out of Miami, with a strong emphasis on fostering innovation within decentralized finance (DeFi) and decentralized infrastructure (DePIN) projects. The firm’s portfolio boasts investments in notable startups such as BlockDaemon, Six Clovers, and Osprey Funds. It also actively supports projects like Peaq, Cudos, and Livepeer, which are revolutionizing areas such as transaction infrastructure and decentralized live streaming. Borderless Capital targets investments globally but has a pronounced focus on the U.S. and Europe. Their investment strategy is geared towards early-stage companies building on Algorand and other blockchain technologies. They lead rounds and typically provide substantial follow-on funding, showcasing their commitment to long-term growth. With a robust team that includes industry veterans like Brian Prilick and Sean Carey, Borderless Capital combines extensive experience in digital entrepreneurship and blockchain technology. The team’s expertise spans investment banking, technological innovation, and market research, making them well-equipped to identify and nurture high-potential startups.

Borealis Ventures is a venture capital firm based in Hanover, New Hampshire, founded in 2002, with a singular focus on transforming healthcare through new therapies, digital innovation, and enabling technologies. The firm invests in life sciences, digital health, and animal healthcare, typically deploying $250,000 to $750,000 per company. Borealis has made 87 investments across five funds — including the Vox Health Fund — and has achieved 24 portfolio exits. The firm leads rounds and maintains a close relationship with the Dartmouth and Tuck academic ecosystem. Notable exits include Glaukos (medical technology for glaucoma) and Repligen (bioprocessing life sciences). Recent portfolio companies include ASTRA Therapeutics, Jenga Biosciences, Triveni Bio, and OvaInnovations (exit recorded November 2024). The data-driven, thematic approach has produced over 50 executed deals across multiple healthcare sub-verticals. Borealis is led by co-founder and Partner Phil Ferneau, who leads healthcare investing, alongside Partners Ben Shaw and Julia Stephanus. The team's collective background in healthcare investment and proximity to New England's research institutions enables early access to academic spinouts and clinician-founded companies at the pre-institutional stage. Borealis places particular emphasis on backing founders who are advancing genuinely differentiated science or platform technologies, rather than incremental product improvements.

Boro Capital is a New York-based venture capital firm that focuses on investing in pre-seed and seed-stage startups across various tech sectors. Established in 2017, the firm targets industries like fintech, SaaS, AI, big data, proptech, and cleantech, among others. Boro Capital’s investment approach centers on identifying early-stage tech companies with the potential to scale rapidly. They leverage a network of strategic partnerships with leading investor groups and accelerators, which helps them source high-potential, pre-vetted startups, streamlining their investment process. The firm typically invests in a company’s first round of institutional funding, cutting checks in the pre-seed and seed stages. With a focus on tech-enabled solutions, Boro Capital has built a diverse portfolio, with over 30 investments in areas like financial software, logistics, and biotechnology. Notable investments include companies like DetraPel, Michroma, and Hailify. Boro Capital’s strategy emphasizes early-stage innovation, aiming to support entrepreneurs through the challenging early phases of scaling their companies. The firm’s portfolio reflects a broad industry focus, from AI and machine learning to climate tech and consumer products. Their approach is designed to capitalize on fast-evolving technologies, making them a key player in helping startups navigate the complex journey from ideation to growth​.

Bose Ventures is the corporate venture capital arm of Bose Corporation, headquartered in Framingham, Massachusetts. Founded in 2015, the fund has up to $50 million allocated for investing in startups building apps, services, or technologies adjacent to the Bose AR platform and broader audio technology ecosystem. The CVC focuses on three core areas — wearables, wellness, and audio — and has made 20 investments across seed through Series B in companies operating in the United States and Europe. The portfolio has produced one unicorn in Whoop (connected fitness wearables), one IPO in Acast (global podcast platform), and five acquisitions including Aaptiv (fitness audio, acquired by Bose). Other portfolio companies include Noise (consumer electronics, most recent investment April 2025), Bragi (wireless earbuds), Beekeeper (B2B workforce productivity), hearX Group (hearing health, led an $8.3 million round), and MedRhythms (digital therapeutics for neurological conditions). As a strategic CVC, Bose Ventures offers portfolio companies access to Bose's engineering teams, acoustic technology platform, global retail and distribution network, and brand credibility — resources that translate into product development advantages and faster paths to market. Managing Director Steve Romine oversees the fund's investment activities. The firm's thesis centers on the belief that audio and sensory technologies are foundational infrastructure for the next generation of health, fitness, and communication products.

Bossanova Investimentos, often referred to as Bossanova Invest, is a prominent venture capital firm based in Brazil, specializing in pre-seed stage investments. Founded in 2011 by Pierre Schurmann and later joined by João Kepler, Bossanova has established itself as the most active micro-VC in Latin America. The firm focuses on B2B and B2B2C technology companies that are innovative, digital, and scalable​​. Bossanova has invested in over 1,200 startups across more than 1,000 companies, making it a significant player in the early-stage investment scene. Their portfolio includes notable exits such as Glovo, Upsie, and Shift​​. They employ a rigorous selection process and offer extensive support to their portfolio companies to ensure rapid growth and success. The firm's investment strategy revolves around startups that are over 1.5 years old, have found a problem-solution fit, and are already operational and generating revenue. They avoid investments in sectors that exclusively target government, e-commerce, games, or hardware that competes with existing portfolio companies​. Bossanova's network includes over 10,000 co-investors, founders, and partner companies, providing a robust ecosystem for startups to thrive. They also offer educational resources through platforms like Clubb.vc, which provides courses and materials on investment, innovation, and business development​​. In addition to traditional equity investments, Bossanova has introduced an innovative investment model via Cédula de Crédito Bancário (CCB), which allows investors to gain exposure to the startup ecosystem with capital protection and fixed returns​​. This approach aims to democratize access to venture capital investments, making it accessible to a broader range of investors.

Boston Seed Capital is a venture capital firm founded in 2011 by Nicole Stata, Peter Blacklow, and David Balter. The firm is based in Boston, Massachusetts, and primarily focuses on early-stage investments in technology-driven industries. Their investment sectors include SaaS, cybersecurity, e-commerce, big data, AI, machine learning, digital media, and marketplaces. Notable investments by Boston Seed Capital include DraftKings, Flywire, and Perch, showcasing their success in backing high-potential startups​ (Boston Seed)​. They are particularly interested in companies that innovate in consumer digital, sports, marketplaces, AI, data, and security. Geographically, Boston Seed Capital concentrates on companies based in Boston and the surrounding areas, leveraging the region's rich entrepreneurial ecosystem​ (Boston Seed)​. Their strategy involves not just providing financial capital but also offering significant operational support and leveraging their extensive network to help startups scale effectively. The firm's leadership includes Nicole Stata, a seasoned entrepreneur and investor with a notable track record, including founding Deploy Solutions and serving as an advisor and board member for various companies​. For startups seeking investment, Boston Seed Capital values innovative ideas and strong entrepreneurial teams. They are committed to building successful businesses that improve life, work, and play through technology​.

Boulder Ventures, established in 1995, is a venture capital firm that focuses on investing in early-stage information technology and life sciences companies. With headquarters in Boulder, Colorado, and an office in the Mid-Atlantic region, the firm leverages decades-long relationships with entrepreneurs and investors to drive its investment strategy. Boulder Ventures has raised eight funds totaling approximately $429 million, with the most recent fund, Boulder Ventures VIII, closing at $58 million in 2022. The firm has a notable track record, having invested in 61 companies, leading to 28 exits and 10 IPOs​. Key investments by Boulder Ventures include companies like Array BioPharma (acquired by Pfizer for $11.8 billion), LeftHand Networks (acquired by HP), and Wall Street on Demand (acquired by Goldman Sachs). The firm’s portfolio is diverse, covering sectors such as software, IT services, storage and communications, and life sciences. Kyle Lefkoff, the founder and general partner, brings over 38 years of venture capital experience. His extensive background includes significant roles in guiding companies through critical growth stages and strategic exits​.

Bow Capital, established in 2016 and based in Menlo Park, California, is a venture capital firm that leverages its strong connection with the University of California system to access a rich ecosystem of academic and research resources. This partnership provides them with broad access to the UC's 2.6 million faculty, staff, students, and alumni, as well as numerous research centers and medical facilities​. Bow Capital invests primarily in early-stage startups, focusing on sectors such as artificial intelligence, machine learning, big data, and enterprise software. Their portfolio includes notable companies like Ambi Robotics, Heartex, and Linus Biotechnology. The firm aims to bridge the gap between academia and industry, helping to commercialize innovative technologies and scientific discoveries. The investment strategy at Bow Capital includes participating in pre-seed, seed, and Series A funding rounds. They emphasize not only financial support but also strategic guidance and operational expertise, leveraging their network of Silicon Valley founders and industry leaders to help startups grow and succeed​. Notable exits for Bow Capital include companies like RealtyShares, Rimeto, and Skylight, reflecting their ability to identify and nurture high-potential startups to successful outcomes.

Bowery Capital is a venture capital firm based in New York City, specializing in early-stage investments in B2B software startups. Founded by Michael Brown in 2013, Bowery Capital focuses on seed stage investments, particularly in SaaS and marketplace business models. Their investment strategy emphasizes hands-on support, aiming to help startups achieve product-market fit and scalable sales operations early on. Notable investments in Bowery Capital’s portfolio include companies like Wizeline, VNDLY, and Codecademy, demonstrating their expertise in backing transformative tech ventures. Their approach is highly selective, investing in only a few deals each year but providing intensive support through their Acceleration Team. This team aids startups in various areas, such as sales, marketing, and business development, ensuring that founders have the resources and guidance necessary to succeed. Bowery Capital is known for leading investment rounds and taking active roles in the growth of their portfolio companies. Their support extends beyond financial investment, with a dedicated advisory network known as the Revenue Council, which connects startups with industry experts for continuous mentorship and strategic advice.

BoxGroup is a prominent early-stage venture capital firm based in New York City, established in 2009 by David Tisch and Adam Rothenberg. The firm focuses on investing in pre-seed to Series A rounds, targeting sectors such as consumer technology, enterprise software, fintech, healthcare, life sciences, and marketplaces. BoxGroup has built a robust portfolio with notable investments in companies like Plaid, Airtable, Ro, Ramp, Warby Parker, and Harry’s. They are known for their early-stage support and have made over 600 investments, actively backing innovative startups with the potential to disrupt and define new market categories. BoxGroup typically invests between $50,000 to $250,000 per deal, emphasizing conviction in the founding teams they support. Their approach is geography-agnostic, although they have a strong presence in key tech hubs such as New York, Silicon Valley, and Los Angeles. The firm has also seen several successful exits, including high-profile IPOs and acquisitions. They aim to be one of the earliest and most supportive investors, providing strategic guidance and leveraging their extensive network to help startups grow and succeed.

BoxOne Ventures, established in 2018 and based in Montreal, Canada, is a venture capital firm that focuses on early-stage investments across diverse and impactful sectors. The firm invests in companies with strong technology platforms in areas such as biotechnology, computational biology, AI and data analytics, digital health, fintech, and food technology. BoxOne Ventures has built a robust portfolio featuring notable investments like Juvena Therapeutics, which raised $41M to advance therapeutic solutions. Other significant investments include companies like dfuse, a blockchain development platform, and Odd Burger, a plant-based fast food chain. The firm’s strategy includes backing talented entrepreneurs and innovative technologies that aim to make a positive difference globally. The team at BoxOne Ventures comprises experienced founders and investors who are deeply involved in the development and support of their portfolio companies. This hands-on approach helps startups navigate the challenges of scaling and achieving market success.

New Science Ventures (NSV), founded in 2004, is a venture capital firm that focuses on investments in life sciences and information technology. With offices in New York and London, NSV aims to leverage breakthrough science to create significant value. The firm has a diverse portfolio, investing in companies that utilize fundamental, science-based innovations to address large unmet needs. NSV's notable investments include Ventyx Biosciences, which raised $114 million to advance its pipeline of immunology programs, and Paragraf, a company that mass-produces graphene electronics. Other significant portfolio companies are Phase Four, which develops next-generation electric propulsion solutions for satellites, and NorthSea Therapeutics, which focuses on novel treatments for liver-related diseases​. The firm typically invests in early to mid-stage companies and supports them through crucial value inflection points to help them scale. Their investment strategy is grounded in strong intellectual property protection and a long-term view​.

Braemar Energy Ventures, founded in 2002, is a New York-based venture capital firm with a strong focus on energy technology and innovation. Notable investments include ChargePoint, Getaround, and Metalenz, showcasing their dedication to transformative energy and tech sectors. They are particularly interested in energy technology, mobility, power, and infrastructure, with a geographic focus primarily on the United States. Braemar's investment strategy revolves around early to mid-stage funding, often leading rounds with substantial check sizes, as seen in Getaround’s $140 million Series E. The firm prides itself on being an active investor, often leading investments and working closely with entrepreneurs to navigate the complexities of the energy transition. Key team members include co-founders William Lese and Neil Suslak, who bring extensive experience and industry connections. Braemar Energy Ventures has a robust track record, with 19 exits including prominent companies like ChargePoint and Viridity Energy. They are approachable for startups looking for engaged and knowledgeable partners in the energy sector, typically through direct networking and industry events. Braemar's team, based mainly in New York, leverages their deep industry expertise to identify and support promising ventures, aiming to drive significant environmental and societal impact through their investments. For startups, aligning with Braemar’s focus on innovation and sustainability in energy technology is key to capturing their interest and securing funding.

Bragiel Brothers is an early-stage venture capital firm founded in 2016 by brothers Paul and Dan Bragiel, based in San Francisco. The fund primarily invests in pre-seed, seed, and Series A rounds, focusing on high-growth industries such as SaaS, fintech, AI, machine learning, and developer tools. Known for its global outlook, the firm has invested in over 60 companies across various regions and industries. Some notable portfolio companies include unitQ, Token Transit, Inspectify, and Memfault. These investments highlight Bragiel Brothers' commitment to backing innovative startups that tackle critical challenges in sectors like big data, IoT, and software development. What sets Bragiel Brothers apart is their hands-on approach, often providing mentorship and strategic guidance to founders alongside capital. This involvement has led to successful exits, including companies like Punchh and Replay, and has positioned Bragiel Brothers as a key player in nurturing early-stage innovation. The firm's leadership, led by Paul and Dan Bragiel, brings extensive entrepreneurial experience, having advised or invested in top-tier companies like Uber, Niantic (of Pokémon Go fame), and Unity. With this deep network and focus on transformative technology, Bragiel Brothers continues to be a valuable partner for early-stage startups looking to scale globally.

Brain Robotics Capital is a venture capital firm established in 2016 with offices in Cambridge, Massachusetts, and Santa Clara, California. The firm focuses on early-stage investments, particularly in startups that are leveraging groundbreaking scientific and technological advancements. Brain Robotics Capital has a strong emphasis on supporting scientist-entrepreneurs, backing companies that work on innovations in artificial intelligence, robotics, and automation. The firm collaborates with incubators, accelerators, and technology transfer offices to help commercialize scientific breakthroughs. Its portfolio reflects its commitment to transformative technologies, investing in startups across sectors such as software, robotics, and AI. By providing both capital and strategic guidance, Brain Robotics Capital helps these companies navigate the challenges of scaling and entering global markets. What sets Brain Robotics Capital apart is its deep technical expertise and hands-on approach. The team, composed of experienced entrepreneurs and technologists, plays an active role in advising and mentoring their portfolio companies, ensuring that their innovative solutions can achieve commercial success. Overall, Brain Robotics Capital is dedicated to fostering innovation at the intersection of technology and science, with a particular focus on sectors that are shaping the future of industries through automation and intelligent systems.

Brand Foundry Ventures is a venture capital firm based in New York, focusing on early-stage investments in consumer brands. Established in 2014 by Andrew Mitchell, the firm has built a portfolio that includes notable companies like Allbirds, Eden Health, and The Wing​. The firm typically leads Series Seed and Series A financing rounds, investing in a wide range of industries such as food and beverage, health care, and consumer technology. Recent investments include Lucky F*ck, Ledgebrook, and Local Infusion​. Brand Foundry Ventures prides itself on its hands-on approach, supporting startups with strategic guidance and leveraging its extensive network to help founders scale their businesses. The firm has made over 120 investments and has had 37 successful exits, showcasing its ability to identify and nurture high-potential startups.

BrandProject is a venture capital firm based in Toronto, Ontario, founded in 2013 by Andrew Black, Andrew Bridge, Jay Bhatti, and Sarah Prevette. The firm specializes in investing in early-stage consumer product, service, and technology companies. BrandProject operates by partnering with founders to accelerate, incubate, and scale their businesses, providing both financial support and operational expertise. BrandProject has raised $54 million for its first venture fund, BrandProject Capital Fund LP, which allows the firm to support founders beyond the early stages of development. The firm typically invests between $500,000 and $5 million in companies, depending on the stage of the startup. They focus on companies that have the potential to disrupt their industries and bring new, innovative products to market. The firm has a strong track record, having invested in 22 companies since its formation. Notable exits include Freshly, which was acquired by Nestle for $1.5 billion, and Hello Products, which was acquired by Colgate-Palmolive. BrandProject's approach involves active participation in the development of their portfolio companies, providing strategic planning, operational support, marketing depth, and more to help these businesses succeed. BrandProject's investment portfolio includes companies like Daily Harvest, Clutch, and Peachy. They continue to focus on identifying market disruptors and supporting their growth to build the iconic consumer brands of tomorrow.

Brandtech Ventures is the strategic venture investment arm of The Brandtech Group, the world's first 'brandtech' holding company founded in June 2015 by former Havas Global CEO David Jones as You & Mr Jones and rebranded to The Brandtech Group in January 2022. Based in New York, the Group helps global brands market better, faster and cheaper by combining owned operating companies, such as the generative-AI marketing platform Pencil, with a portfolio of strategic minority investments in the technologies most likely to reshape brand marketing. Brandtech Ventures invests at Seed, Series A and Series B across adtech, martech, generative AI, big data and analytics, AR/VR and the metaverse, influencer marketing and gaming. Its portfolio of roughly 26 named investments includes Niantic, the Pokémon GO creator the firm backed as one of the earliest external investors after its 2015 spinout from Google, alongside Crossing Minds, Zappar, Jivox, Automat, Elsy, VidMob, CreativeX, AI Foundation, Provenance and Pixlee-TurnTo. The Brandtech Group raised a $115M Series C in March 2024 at a $4 billion valuation from Fimalac and NendoLabs alongside Mousse Partners and Bansk Group, bringing total Group capital raised to roughly $373 million. Leadership includes founder and CEO David Jones, Global CFO Matthieu Pigasse, the former Lazard banker who joined in 2024, and Partner and Head of Emerging Technologies Rebecca Sykes. As a strategic investor rather than a lead, Brandtech Ventures pairs capital with the Group's operating platform to commercialise the next generation of marketing technology.

Bread and Butter Ventures, based in Minneapolis, Minnesota, is an early-stage venture capital firm that invests globally while leveraging the region's strong corporate connections and industry expertise. Founded in 2017, the firm focuses on several key sectors including health tech, food tech, and enterprise SaaS. Their portfolio includes notable investments such as Ducky, an automation and workflow software company; Chiyo, which focuses on food and agriculture technology; SocialCrowd, a platform for enterprise applications; and Nest Collaborative, a health tech company providing virtual lactation support. They have made a total of 87 investments, emphasizing their active involvement in the startup ecosystem. Bread and Butter Ventures has also seen successful exits, including Upsie, a technology company that was acquired, and Spoonshot, which was also successfully exited. The firm is led by Managing Partners Brett Brohl and Mary Grove, who bring extensive experience in technology and early-stage investing.

Break Off Capital is a dynamic investment firm dedicated to expanding human potential through science and technology. Their mission is driven by the "Break Off" phenomenon—a cognitive shift in awareness recognizing the fragility of life and the imperative to protect and advance our world. The firm is committed to solving global challenges by channeling resources into cutting-edge scientific and technological advancements. Notable divisions include Break Off Capital, which focuses on funding groundbreaking scientific projects; Break Off Crowd, a platform for community-driven scientific support; and Break Off Labs, which connects researchers with funders to facilitate pioneering research. The team is led by Ricardo Celaya, who brings a wealth of experience from his background in art, finance, and private equity, and Victor Celaya, who has a strong background in media and innovation. They are supported by a network of corporate and scientific advisers, including Shervin Kamkar from Illumina and Dr. Leslie Dewan, a nuclear engineer and conservation technologist. Break Off Capital invests in early-stage ventures that address significant societal issues, emphasizing collaboration and strategic support to foster innovation and impact. Their approach is to integrate financial backing with expert mentorship, ensuring that startups not only receive funding but also the guidance needed to scale effectively.

Break Trail Ventures is an early-stage venture capital firm based in Columbus, Ohio, and Boulder, Colorado. Founded in 2018, the firm focuses on investing in startups that are innovating in sectors such as consumer products, advanced manufacturing, big data, digital health, e-commerce, mobile, SaaS, and the Internet of Things. The firm has built a diverse portfolio that includes notable companies like Cotopaxi, an outdoor gear brand committed to sustainability; Oiselle, a women's athletic apparel company; and Pepper, a lingerie brand designed for smaller cup sizes. Break Trail Ventures aims to support entrepreneurs who are pioneering new paths in their industries, emphasizing a customer-first approach and solving significant problems. Break Trail Ventures operates with a mission to partner closely with founders, providing not only capital but also strategic guidance to help startups achieve product-market fit and scale effectively. The firm is led by Managing Partner Jay Hirsh, who brings extensive experience in venture capital and entrepreneurship..

Breakaway Ventures is a consumer brand-focused venture capital firm based in Waltham, Massachusetts, founded in 2006 by Dennis Baldwin. The firm invests exclusively in emerging consumer brands — food and beverage, personal care, sports and fitness, wellness, and self-care — targeting companies that have already crossed $2 million in revenue and are seeking $3 million to $8 million in growth capital to reach the next inflection point. Breakaway leads rounds and manages less than $150 million across five private funds, with 37 investments and 17 exits to date. Portfolio companies include Plaza AI (most recent investment, April 2025), XSET (gaming and entertainment), and Lark (clinics and health services). The investment thesis is tightly scoped: the firm backs only consumer brands, at a specific revenue threshold, with a concentrated focus that allows the team to bring genuine category expertise and a deep capabilities network to each portfolio company. Dennis Baldwin leads the firm as Founder and Managing Partner, supported by Principal Jody O'Neill. Breakaway's model holds that consumer brands at their inflection point are best served not by generalist capital but by an investor with operational depth in brand building — one who can accelerate revenue growth and value creation through direct involvement in go-to-market strategy, retail channel expansion, and brand positioning rather than simply deploying capital.

Breakout Labs, founded in 2012 as part of the Thiel Foundation, is an incubator and venture fund that supports early-stage, deep science companies with radical and emerging technologies. The fund provides up to $350,000 in initial funding and extensive support for startups that are too speculative for traditional venture capitalists. Breakout Labs focuses on companies at the intersection of technology, biology, materials, and energy, aiming to transition groundbreaking scientific discoveries from the lab to the market​. Notable portfolio companies include SciBac, which targets antibiotic-resistant diseases through microbiome science, and Azitra, which leverages the skin’s microbiome to treat skin diseases. Other innovative investments include ZymoChem, which develops sustainable chemical production processes, and EpiBone, which grows custom bones using 3D imaging and stem cells​. Breakout Labs has a history of significant follow-on funding for its portfolio companies, totaling over $1 billion. This success underscores their commitment to supporting the entire lifecycle of their investments, from seed to scale. The team, led by Managing Partners Lindy Fishburne and Julia Moore, includes experts who provide strategic guidance and leverage a vast network of founders, corporate partners, and advisors.

Breakout Ventures is a San Francisco-based venture capital firm founded in 2016, focused on early-stage investments in creative bioscience companies. The firm is dedicated to supporting startups that leverage the convergence of biology, chemistry, and technology to develop bio-based solutions aimed at improving human health and sustainability​. Breakout Ventures has raised significant capital, including a $112.5 million Fund II, to back innovative companies at the intersection of technology and biology. Their investment portfolio includes companies like Immusoft, which is working on genetically modifying B cells for sustained therapeutics, and Checkerspot, which uses synthetic biology to produce bio-derived oils​. The firm's investment strategy targets areas such as synthetic biology, cell and gene therapy, biomanufacturing, and carbon transformation, supporting companies from seed to scale. Notable portfolio companies include Cytovale, which focuses on diagnosing immune-mediated diseases, and Ecovative Design, which uses mycelium technology for sustainable materials. The Breakout Ventures team, led by managing partners Lindy Fishburne and Julia Moore, brings extensive experience in supporting science-driven companies. The firm originated from Breakout Labs at the Thiel Foundation, which has a strong history of advancing early-stage deep science startups​.

Breakthrough Energy Ventures, part of the Breakthrough Energy network founded by Bill Gates, focuses on financing and scaling companies that aim to eliminate greenhouse gas emissions globally. With over $3.5 billion in committed capital, BEV invests in more than 110 cutting-edge companies across various stages, from seed to growth. The firm targets technologies capable of significantly reducing greenhouse gases, aiming for at least half a gigaton reduction annually. Key areas of investment include clean hydrogen, long-duration energy storage, sustainable aviation fuel, direct air capture, and green manufacturing. BEV supports companies like H2Pro, which innovates in green hydrogen production, and Heirloom, focused on cost-effective carbon removal. BEV’s strategy involves more than just funding; it provides comprehensive support, including technical, operational, market, and policy expertise to help companies overcome scaling challenges. This holistic approach ensures that new climate technologies can transition from development to widespread commercial adoption. The team at BEV includes experts like Eric Toone, Technical Lead of the Investment Committee, and Megan Wenrich, Vice President of Development. These professionals bring a wealth of knowledge and experience to guide the firm’s investments and initiatives.

Brewer Lane Ventures is an early-stage venture capital firm based in Boston, Massachusetts, founded in 2019 by John Kim. The firm focuses on investing in fintech and insurtech startups, aiming to transform the financial services and insurance industries. Brewer Lane leverages its deep industry expertise and extensive network to provide strategic guidance and support to its portfolio companies, helping them scale and achieve market leadership. The firm's investment strategy includes backing founders who are reimagining financial services, with a typical investment range of $1 million to $10 million. Brewer Lane Ventures has raised substantial capital for its funds, with its first fund securing around $120 million and its second fund closing at $203 million​. Brewer Lane Ventures' notable investments include companies like Empathy, January, and Codoxo, which focus on various aspects of application software, financial software, and healthcare enterprise systems. The firm is known for its hands-on approach, providing both financial support and strategic advice to help its portfolio companies navigate their growth trajectories successfully.

Breyer Capital is a premier venture capital firm founded by Jim Breyer in 2006. The firm focuses on catalyzing high-impact entrepreneurs across various sectors, including artificial intelligence, digital health, and fintech. Notable investments from Breyer Capital include Facebook, Spotify, 23andMe, and Zoox, with Zoox being acquired by Amazon. Breyer Capital invests in early-stage startups, particularly those in the AI, healthcare, and consumer tech industries. The firm's approach is founder-centric, emphasizing long-term partnerships and hands-on engagement. They typically participate in pre-seed, seed, and Series A funding rounds. Geographically, Breyer Capital has a broad focus, investing in companies across the United States, Europe, and beyond. The firm is headquartered in Menlo Park, California, but also has a significant presence in Austin, Texas. Key figures at Breyer Capital include founder Jim Breyer and partner Daniel Breyer. The team is known for its deep industry connections and strategic guidance, supporting portfolio companies with both capital and mentorship. Breyer Capital's recent investments include Atropos Health, Nimble Robotics, and Elemental Cognition, highlighting their commitment to innovative solutions in AI and healthcare. The firm's long-term vision and robust support structure make it a vital player in the venture capital landscape.

Brick & Mortar Ventures, established in 2015 and based in San Francisco, focuses on investing in innovative solutions within the architecture, engineering, and construction (AEC) and facilities management sectors. The firm targets both software and hardware solutions aimed at transforming the construction industry by improving efficiency, productivity, and safety. Their notable investments include companies like PlanGrid, Fieldwire, BuildingConnected, and Levelset. These companies have pioneered various advancements, such as digital blueprints, construction management software, and lien waiver management tools. Brick & Mortar Ventures has also supported startups like SafeAI, which develops autonomous equipment, and Curbio, which specializes in pre-sale home renovations. The firm is led by Darren Bechtel, who brings extensive experience and industry connections to support portfolio companies. The team also includes Curtis Rodgers, Kaustubh Pandya, and Guillaume Bazouin, who provide expertise in industrial technology, strategy, and European market investments, respectively. Brick & Mortar Ventures takes a hands-on approach, working closely with startups to leverage their deep industry knowledge and network to foster growth and innovation. They aim to disrupt traditional construction practices and drive the adoption of new technologies across the AEC sector​.

Bridge Investments, based in Chicago, is a private equity firm that focuses on lower middle-market companies across various sectors. The firm invests in diverse industries including technology, healthcare, and consumer products. Some of their notable investments include companies like In Good Taste, which enhances the wine tasting experience, and LegalMation, an AI-powered platform transforming litigation. Bridge Investments emphasizes partnering with dynamic founders and building collaborative relationships to foster sustainable growth. They take a hands-on approach, often involving their experienced team members in strategic guidance and operational support. The team includes co-founders Daniel Goldberg and Robert Goldberg, who bring decades of expertise in law and investment, along with Jason Thomas and Tim Schlidt, who contribute deep insights in venture capital and healthcare investments. Their portfolio showcases a wide range of successful investments, such as Classkick, an educational technology platform, and ConverseNow, a voice AI platform for quick-service restaurants​​. Bridge Investments is committed to creating value and supporting the growth of their portfolio companies through a collaborative and resourceful investment approach.

BrightEdge Fund is the philanthropic impact investment arm of the American Cancer Society (ACS), established in 2019. Headquartered in Kennesaw, Georgia, BrightEdge focuses on accelerating the commercialization of innovations in cancer care. The fund aims to reduce cancer mortality, alleviate pain and suffering, and advance health equity by investing in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, and technologies. Notable investments in BrightEdge’s portfolio include Checkmate Pharmaceuticals, an immunotherapy drug developer; Freenome, a biotech company specializing in early cancer detection through liquid biopsy; and TailorMed, which provides patient financial navigation software. The fund has also invested in Catena Biosciences and Clasp Therapeutics. BrightEdge has a strong track record of exits, with companies like Castle Biosciences going public and Tmunity being acquired. The fund leverages the ACS’s extensive research and expertise to mitigate risks associated with health science investments. This affiliation allows BrightEdge to provide valuable insights into the competitive landscape and regulatory environment, enhancing the potential for successful commercialization of its portfolio companies​. Managed by a team of experienced professionals, including Managing Director Alice Pomponio, BrightEdge also serves as a follow-on investor and board observer, working alongside prominent venture capital firms to support its mission. The fund’s current fundraising target is $100 million, aiming to sustain ACS’s life-saving programs and further its impact.

Bright Ventures is a New York-based venture capital firm focused on building inclusively-led, early-stage companies in industries like fintech, digital health, and the future of work. With a mission centered on creating an inclusive economy, they specialize in Pre-Seed and Seed investments, aiming to unlock human potential through technology-driven innovation. Their portfolio includes companies like Mae Health and Options MD, showcasing their commitment to healthcare and financial services. Bright Ventures looks for transformative startups led by diverse founders, leveraging its proprietary "Inclusive Innovation" model to promote sustainable, inclusive business practices. The firm’s founder, Lenore Beirne, and a strong team of partners, including Noradeen Farlekas and Isha Vij, bring leadership and investment expertise, providing not only capital but also leadership coaching and advisory services through programs like their Leadership Accelerator. Based in New York, they have a U.S.-focused investment strategy. Bright Ventures typically leads early rounds and is highly selective, with a preference for companies that align with their inclusive and stakeholder-driven values. For founders looking to engage, the firm values authentic, mission-driven pitches that emphasize both innovation and impact.

BrightEdge is the innovation and impact investment arm of the American Cancer Society (ACS), founded in 2018 and based in Kennesaw, Georgia. A donor-funded philanthropic impact fund, BrightEdge invests in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, medical devices, and enabling technologies. Through the end of 2024, the fund has deployed $52 million across 22 companies, with 15 active portfolio companies holding potential to impact 13.4 million patients. The fund invests globally — across the United States, Canada, Europe, and Asia-Pacific. Investments are aligned with ten American Cancer Society mission priority areas, including cancer health equity, patient survivorship, disease prevention, clinical trial accessibility, and care quality. Recent portfolio companies include Signify Bio (in vivo therapeutics, 2024). BrightEdge also runs the BrightEdge Entrepreneurs program to support founders navigating the early stages of cancer innovation. Managing Director Alice Pomponio brings experience from Red Sky Partners and teaches biomedical innovation at MIT; Director of Investments Lucas de Breed leads deal sourcing and execution. BrightEdge distinguishes itself from pure financial investors by reinvesting all financial returns back into the American Cancer Society's scientific and patient advocacy programs, making every exit outcome directly compound the mission. The fund operates with a dual mandate: achieving genuine venture returns while ensuring the ACS remains a financially self-sustaining engine for cancer research for decades ahead.

Brighter Capital, based in Cupertino, California, is a venture capital firm founded in 2020. It primarily focuses on early-stage investments, particularly in Pre-Seed, Seed, and Series A rounds. The fund invests across a variety of sectors, including SaaS, edtech, healthtech, renewable energy, AI, and cybersecurity. Their portfolio includes notable companies like Reddit, Calm, and Envoy, showing a strong interest in disruptive technologies and companies that impact the future of work, energy, and healthcare. The firm's typical check size ranges from $50K to $250K, supporting startups with a clear focus on long-term growth. Brighter Capital often co-invests with other funds and focuses heavily on providing strategic support to its portfolio companies, including advisory and consulting services. Notable recent investments include Vectara and BlockSpaces. Led by Yun-Fang Juan, Brighter Capital is also known for backing unicorns, with several companies in their portfolio reaching billion-dollar valuations.

Brighteye Ventures is Europe's first and largest dedicated edtech venture capital firm, founded in 2017 with offices in Paris, London, and Luxembourg. The firm backs founders shaping what it calls the 'HumanOS' — enabling people to learn, work, and adapt throughout their lives. Brighteye closed its second fund at €100 million, doubling Fund I and bringing total assets under management to €150 million. The firm invests €400,000 to €4 million at pre-seed through Series A, primarily in European startups using technology to enable learning, skills acquisition, or research. Brighteye leads rounds and has built a portfolio of 48 companies. Two portfolio companies have been acquired — Epic and Beekast — across a portfolio weighted heavily toward education (30 companies), SaaS, AI, and HR technology. Partners Alex Latsis and Benoit Wirz have spent over a decade building and investing in European and North American edtech, giving the six-person team a network that spans both founders and corporate buyers. Brighteye's investment thesis focuses on the intersection of learning, entertainment, and creativity — backing companies that expand human potential rather than merely digitizing existing curricula. The firm supports portfolio companies through product refinement, partnership development, and geographic expansion, drawing on long-standing relationships with European universities, enterprise L&D buyers, and media partners that would be difficult for a generalist fund to replicate.

Brightstone Venture Capital is a venture capital firm based in Minneapolis, Minnesota, established in 1985. The firm focuses on early-growth stage investments in technology and life sciences sectors. With a strong track record, Brightstone manages multiple venture partnerships and currently oversees a $100 million fund aimed at supporting innovative startups. Brightstone's portfolio includes notable companies like VRChat, Celcuity, Bite Squad, and StemoniX, which have achieved significant milestones such as IPOs and major acquisitions. For instance, Bite Squad was sold to WAITR Holdings for $321 million, and StemoniX went public on NASDAQ under the ticker VYNT. The firm is led by experienced partners, including David Dalvey, Jeffrey Cowan, and Patrick O'Shaughnessy, who bring deep expertise in venture investing and entrepreneurship. Brightstone is known for its hands-on approach, providing strategic guidance and operational support to help portfolio companies scale and succeed. Brightstone Venture Capital has made 62 investments and has had 25 successful exits, showcasing their ability to identify and nurture high-potential startups. Their investments span various industries, including biotechnology, software, virtual reality, and medical technology​.

Broadband Venture Partners was a venture capital firm based in Dallas, Texas, founded in 2000, focused on investments in broadband, telecommunications, and digital media companies. The firm operated during the early broadband and telecom infrastructure buildout and made at least two recorded investments — Voxitas and HighWired.com — in internet services and business productivity software. The most recent recorded investment dates to January 2003. The firm ceased operations as of April 25, 2023. Very limited public information is available about the team composition, total fund size, or exit outcomes. The firm appears to have been most active during the early 2000s telecommunications boom and did not maintain a significant public profile after that period. Broadband Venture Partners operated at a time when broadband infrastructure was transitioning from enterprise to consumer markets, a window that produced both significant failures and durable winners across the telecom and digital media sectors. The firm's narrow sector focus and early vintage place it in the cohort of specialized telecom-era VCs whose strategies were closely tied to the infrastructure buildout cycle of that era.

Broadview Ventures, founded in 2008 and headquartered in Boston, Massachusetts, is a venture capital firm focused on investing in early-stage life sciences companies. The firm specializes in cardiovascular and neurovascular diseases, aiming to bridge the translational gap between scientific research and clinical application. Broadview Ventures has a robust portfolio that includes companies such as DecImmune Therapeutics, which develops therapies to mitigate injury post-myocardial infarction, and FineHeart, a French medical device company creating innovative cardiac support technologies. Other notable investments include GI Windows, developing non-surgical approaches for treating chronic diseases, and Adient Medical, focusing on absorbable medical devices. The firm has made 79 investments and achieved several successful exits, including Cardialen, VentriNova, and Renovacor. Broadview's investment strategy leverages their extensive industry expertise and network to support companies from seed through later stages of development. Broadview Ventures is led by a team of experienced professionals dedicated to advancing healthcare through innovative solutions. Their strategic focus and targeted investments aim to address unmet medical needs, ultimately improving patient outcomes and advancing the field of cardiovascular and neurovascular health.

Broadway Video Ventures (BVV) is the corporate venture capital arm of Broadway Video, the entertainment company founded by Lorne Michaels — creator and long-running producer of Saturday Night Live. Based in New York City and active since 2011, BVV targets early and growth-stage investments, acquisitions, partnerships, and joint ventures across media, entertainment, and technology. The fund deploys a minimum of $1.1 million and can commit up to $34.3 million in a single investment, with a portfolio of 14 companies across media, SaaS, gaming, and health tech. Notable portfolio companies include Headspace (meditation and mental wellness app, now merged with Ginger to form Headspace Health), Houseparty (social video app, acquired by Epic Games), and Futurefly (gaming). BVV also incubated Above Average, a digital comedy network. The broader Broadway Video library — spanning SNL, The Tonight Show, and other marquee television properties — gives the firm unique access to talent relationships, content licensing opportunities, and entertainment industry networks. BVV's investment thesis is rooted in the belief that media, entertainment, and technology are converging irreversibly, and that a capital partner with deep content industry relationships can offer technology startups distribution, talent, and branding advantages that pure financial investors cannot. The five-partner team evaluates opportunities through the lens of Broadway Video's ability to add strategic value beyond capital.

Bronze VC is an impact-oriented early-stage venture capital firm founded in 2009 by Stephen DeBerry, based in East Palo Alto, California. The firm invests in high-growth technology companies that move social, economic, and environmental disparity toward prosperity, with a thesis centered on deploying emerging technical capabilities into historically overlooked communities — and finding entry points at low valuations that yield strong financial returns alongside social impact. Bronze is listed on the ImpactAssets 50, a recognized benchmark for impact fund managers. Fund I raised $23 million and has been recognized as a top quartile performer by TVPI across US venture capital as measured by Cambridge Associates. Fund II targeted $75 million. The portfolio of 17 companies spans software, fintech, AI, health, and education sectors. Bronze leads rounds at seed and Series A, typically deploying $500,000 to $3 million. Stephen DeBerry is recognized as a leading practitioner of impact investing that does not sacrifice return discipline. Bronze's strategy rests on the observation that historically underserved geographies and demographics have been systematically undercapitalized — creating a valuation gap that disciplined investors can exploit while also driving measurable social outcomes. The firm's track record suggests that inclusion and financial performance are complementary, not competing, investment goals.

Brooklyn Bridge Ventures (BBV), founded in 2012 by Charlie O'Donnell, is a pioneering early-stage venture capital fund based in Brooklyn, New York. BBV primarily focuses on leading or co-leading pre-seed and seed rounds, targeting startups in the New York City area that have raised less than $750,000 in prior funding rounds. BBV has a diverse portfolio, investing in sectors such as B2B SaaS, eCommerce, Fintech, Foodtech, and Healthcare. Some of their notable investments include Hungryroot, Brigit, and Yuvo Health. These companies have seen significant growth and success, reflecting BBV's ability to identify and nurture promising startups. The firm is known for fostering a strong community among founders and professionals, providing extensive support and guidance to early-stage startups. They typically invest around $350,000, focusing on companies with well-researched ideas, working prototypes, or early traction with users or revenue. As of May 2023, BBV announced that it would no longer be making new investments. Despite this, the firm continues to support its existing portfolio companies, helping them navigate growth and sustainability challenges. For startups seeking engagement, BBV's legacy emphasizes the importance of strong preparation and clear demonstration of potential.

Broom Ventures is a dynamic venture capital firm specializing in early-stage investments, primarily in pre-seed and seed rounds. The fund is known for its robust portfolio that includes notable startups like Epirus, an AI-driven defense technology company, and Anduril, which focuses on AI-based surveillance and reconnaissance solutions. Both of these companies have reached unicorn status, underscoring Broom Ventures' knack for identifying high-potential tech ventures. Broom Ventures predominantly invests in disruptive technologies across various sectors, including financial services, consumer products, and life sciences. Their geographic focus spans the United States, with notable investments also in Latin America and Europe. Companies like Kapital, a data-driven neobank for SMBs in Latin America, and NuView, which provides satellite-based LiDAR mapping, highlight their diverse global reach. The fund adopts a hands-on strategy, providing substantial support beyond capital, aiming to help startups achieve their full potential. They typically lead funding rounds, with investment amounts ranging from $250k to $750k. Recent investments include Kento Health, a cardiac rehabilitation software company, and NUVIEW, highlighting their continued activity in the market. The leadership team includes industry veterans like Dan Von Kohorn and Jeff Rosen, who bring extensive experience in both tech and investment management. This expertise is crucial for their approach to building strong, innovative companies. For startups looking to engage with Broom Ventures, it's essential to demonstrate a clear potential for disruption and scalability. They value solid business models and innovative solutions that address significant market needs.